Q3 : EARNINGS CALL HIGHLIGHTS: Looking at the last 8 quarters, our ability to exceed the rule of 40 is not a series of anomaly or a one-off success. Quite the opposite, we are outperforming the industry because we are built on the fundamental recognition that adtech must be able to respond, underlying response to the trend with ability and agility. Revenue of...
In the light of a recession with the GDP seeing negative growth in Q1 and a tighter monetary policy from Fed as well as rate hikes from Fed does the high profile growth stocks see a slow down. The main buyer of these high profile growth stocks is NASDAQ where many of these stocks see a bearish market (e.g. Meta Platforms, Zoom and Netflix) as investors go from...
CrowdStrike: Another Solid Quarter; Buy Opportunistically ~ After solid F1Q22 results, we reiterate our buy rating on CrowdStrike. We urge long-term investors to buy shares on weakness and existing shareholders to remain invested in the stock. ~ Elevated security spending, new customer additions and upsells into its install base, low churn, and displacement of...
Intellia's Data Has Underlined Huge Potential Of Gene Therapeutics And There Will Be More Soon Summary : Intellia is a gene therapy specialist pioneering CRISPR-Cas9 technology. Its recently released data in ATTR Amyloidosis stunned analysts, showing mean reduction in TTR Serum levels of up to 96%. This was the first ever clinical proof of the safety and...
Datadog's (DDOG) stock is not cheap, but the company is highly innovative and showing no signs of slowing down. To illustrate, not only is Datadog's guidance for the year strong, but its billings were up 69% y/y as of Q2 2021. Having said that, at 32x next sales, the stock is far from cheaply valued. Investors intent on being shareholders here should look to...
$SAVA (Cassava Sciences) saw an insane rally in 2021 from $7 to $145 on the hopes that its groundbreaking Alzheimer's treatment will yield promising results never before seen in the history of the disease. Currently there are no Alzheimer's modifying therapies on the market and if the data surrounding Cassava's main drug, simufilam, is accurate then it could be...
Srac (Momentus), is a Space company, possibly ARKX target. Support: 22$ (volume pad); 20$ (strong support) PT1: 40$ /R3/ (pre merge price target)
INPX the IoT company, hourly chart. The closing of the offering is expected to occur on or about February 18, 2021 subject to the satisfaction of customary closing conditions. finance.yahoo.com After closing the offering it could jump nice. Offering price: 2.01$ Support: 1.69$ (volume pad) Resistance: 2.15$ (Pivot Point) PT1: 4$ (R3)
TRXC robot surgery company, with unique laparoscopy technology called Senhance. You can see more on February 23. on a virtual conference. finance.yahoo.com PT1: 6.5$ done TOP: 6.95$ Between R1 (4.74) - MA20 (4.14) Moderated BUY, under 4.14 (blue arrow) Strong BUY and they also have some good news today. finance.yahoo.com PT2: 10.10$ /R4 - blue arrow/
besides the fundamentals, the chart has a lot to offer we can see here, that it can be at the top, almost ready to fall back, even to $4 per share. tho, as we can also see here, it can also be the last low, after that we will see a parabolic upturn, that could drive the price +10x in less than 3 months. or else, as we can see here, price is at top of the...
$STUDY #UNITEDTRADERS
Breakout incoming!
ER this week
4-WK CONSOLIDATION BREAKING OUT OF PATTERN RESISTANCE. 38% PRICE RETRACEMENT ON PROFIT TAKING. OBSERVE VOLUME ACCELERATION FOR TRADE ENTRY CONFIRMATION.
6 WK CONSOLIDATION ON THE BACK +124% PRICE RALLY FROM MARCH BOTTOM. +980% EARNINGS GROWTH ON THE PREVIOUS QUARTER, +44% REVENUE GROWTH, AND POSITIVE EARNINGS REVISION.
6-week consolidation pattern with price finding support on 38.2% Fib retracement. Revenue growth >30% YoY Gross profit margin >80% Positive Cash Flow
will save adds for 280s
Ollie’s Bargain Outlet Holdings, Inc. Provides Second Quarter Outlook Ollie's Bargain Outlet Holdings Inc : • OLLIE’S BARGAIN OUTLET HOLDINGS, INC. PROVIDES SECOND QUARTER OUTLOOK • OLLIE'S BARGAIN OUTLET HOLDINGS INC - FOR Q2 OF FISCAL 2020 EXPECTS TOTAL NET SALES OF ABOUT $515 MILLION • OLLIE'S BARGAIN OUTLET HOLDINGS INC - FOR Q2 OF FISCAL 2020 EXPECTS...